摘要 |
The present invention relates generally to a method of determining one or more probabilities of respective classifications of a neoplasm into one or more neoplastic categories. More particularly, the present invention relates to a method of determining the probability of classification of a large intestine neoplasm into one or more categories selected from adenoma, stage I, stage II, stage III or stage IV by screening for changes to the methylation levels of a panel of gene markers, including BCAT1, IKZF1, IRF4, GRASP and/or CAHM. The method of the present invention is useful in a range of applications including, but not limited to, those relating to the diagnosis and/or monitoring of colorectal neoplasms, such as colorectal adenocarcinosis. |
申请人 |
CLINICAL GENOMICS PTY. LTD. |
发明人 |
LAPOINTE, LAWRENCE CHARLES;PEDERSEN, SUSANNE, K.;BAKER, ROHAN;GAUR, SNIGDHA;THOMAS, MELISSA |